US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kardigan

19.68

-1.9200-8.89%

Pre-market: 20.000.3200+1.63%04:01 EDT

Volume:382.86K

Turnover:7.71M

Market Cap:1.84B

PE:-6.37

High:22.00

Open:21.44

Low:19.62

Close:21.60

52wk High:27.00

52wk Low:16.25

Shares:93.50M

Float Shares:23.33M

Volume Ratio:1.09

T/O Rate:1.64%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0900

EPS(LYR):-14.8367

ROE:--

ROA:--

PB:2.99

PE(LYR):-1.33

Loading ...

Overview Company News Filings

Kardigan to Present at Cantor Global Healthcare Conference Fireside Chat

Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch

Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar

Kardigan Price Target Cut to $46.00/Share from $51.00 by JP Morgan

Kardigan price target lowered to $46 from $51 at JPMorgan

Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate

Benzinga Earnings

Kardigan Q2 Per-Share Loss Narrows

MT Newswires Live

Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share

MT Newswires Live

Kardigan reports Q2 EPS ($4.61) vs ($4.64) last year

Kardigan Q2 FY26 Net Loss Widens to $116.24 Million; R&D Expenses Rise to $56.37 Million

Kardigan - Q2 Net Loss was $116.20 Mln

THOMSON REUTERS

Press Release: Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

TD Cowen Initiates Kardigan at Buy With $46 Price Target

MT Newswires Live

Leerink Partners Initiates Kardigan at Outperform With $37 Price Target

MT Newswires Live

Kardigan Initiated at Buy by Jefferies

Kardigan initiated with an Overweight at JPMorgan

Kardigan initiated with a Buy at Jefferies

Kardigan Inc : Jefferies Initiates Coverage with Buy Rating; Target Price $40

THOMSON REUTERS

Massive Insider Buying Spree Signals Bold Confidence in Kardigan’s Future

ARCH Venture Fund XIII Acquires $20 Million of Kardigan Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/KARD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","market":"US","secType":"STK","nameCN":"Kardigan","latestPrice":19.68,"timestamp":1788984000000,"preClose":21.6,"halted":0,"volume":382861,"hourTrading":{"tag":"盘前","latestPrice":20,"preClose":19.68,"latestTime":"04:01 EDT","volume":1,"amount":20,"timestamp":1789027262811,"change":0.32,"changeRate":0.01626,"amplitude":0},"delay":0,"changeRate":-0.08888888888888896,"floatShares":23333300,"shares":93503699,"eps":-3.09,"marketStatus":"Pre-Mkt","change":-1.92,"latestTime":"09-10 05:52:34 EDT","open":21.44,"high":22,"low":19.62,"amount":7712448.847832999,"amplitude":0.110185,"askPrice":22.68,"askSize":100,"bidPrice":17.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.09,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1781755200000,"exchange":"NASDAQ","adjPreClose":19.68,"preHourTrading":{"tag":"盘前","latestPrice":20,"preClose":19.68,"latestTime":"04:01 EDT","volume":1,"amount":20,"timestamp":1789027262811,"change":0.32,"changeRate":0.01626,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":20,"preClose":19.68,"latestTime":"19:30 EDT","volume":413,"amount":8150.98,"timestamp":1788996607706,"change":0.32,"changeRate":0.01626,"amplitude":0.01626},"volumeRatio":1.0860959876256764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KARD\",,,,,undefined,":{"symbol":"KARD","floatShares":23333300,"roa":"--","roe":"--","lyrEps":-14.836702,"volumeRatio":1.0860959876256764,"shares":93503699,"dividePrice":0,"high":22,"amplitude":0.110185,"preClose":21.6,"low":19.62,"week52Low":16.25,"pbRate":"2.99","week52High":27,"institutionHeld":0,"latestPrice":19.68,"eps":-3.09,"divideRate":0,"volume":382861,"delay":0,"ttmEps":-3.09,"open":21.44,"prevYearClose":16,"prevWeekClose":20.85,"prevMonthClose":20.16,"prevQuarterClose":23.85,"fiveDayClose":19.6,"twentyDayClose":22.06,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KARD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KARD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KARD","date":"2026-09-09","current":-6.368932,"percent":0.740741,"low":-10.060668,"twenty":-8.883686,"median":-8.153414,"eighty":-6.773566,"high":-6.34617,"avg":-7.980489,"sd":1.010727,"marketCap":2019679898},"quantilePoints":[{"date":"2026-06-26","current":-8.771038,"twenty":-8.785799,"median":-8.638967,"eighty":-8.555064,"marketCap":2017277352},{"date":"2026-07-02","current":-9.365355,"twenty":-9.304758,"median":-8.844842,"eighty":-8.606338,"marketCap":2153966207},{"date":"2026-07-10","current":-9.497426,"twenty":-9.402646,"median":-9.202209,"eighty":-8.63586,"marketCap":2184341508},{"date":"2026-07-17","current":-8.165067,"twenty":-9.402646,"median":-9.140059,"eighty":-8.601677,"marketCap":1877908323},{"date":"2026-07-24","current":-8.417555,"twenty":-9.304758,"median":-8.862322,"eighty":-8.544187,"marketCap":1935978752},{"date":"2026-07-31","current":-7.951424,"twenty":-9.261253,"median":-8.708887,"eighty":-8.273054,"marketCap":1828771806},{"date":"2026-08-07","current":-7.908695,"twenty":-9.248823,"median":-8.631199,"eighty":-8.113793,"marketCap":1818944503},{"date":"2026-08-14","current":-7.061734,"twenty":-9.209201,"median":-8.551568,"eighty":-7.960747,"marketCap":2039315675},{"date":"2026-08-21","current":-6.559868,"twenty":-9.156374,"median":-8.417555,"eighty":-7.800708,"marketCap":1894384941},{"date":"2026-08-28","current":-6.734712,"twenty":-9.043725,"median":-8.227218,"eighty":-7.055906,"marketCap":1944876939},{"date":"2026-09-04","current":-6.715284,"twenty":-8.891455,"median":-8.165067,"eighty":-6.786517,"marketCap":1939266717},{"date":"2026-09-09","current":-6.993739,"twenty":-8.883686,"median":-8.153414,"eighty":-6.773566,"marketCap":2019679898}],"updateTime":1789033954424},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KARD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664493008","title":"Kardigan to Present at Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664493008","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664493008?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:06","pubTimestamp":1788379594,"startTime":"0","endTime":"0","summary":"Kardigan to present at Cantor Global Healthcare Conference fireside chatKardigan will join the 2026 Cantor Global Healthcare Conference on Sept. 9, 2026, featuring a 1:35 p.m. ET fireside chat.It will","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLl4CkH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843540","title":"Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843540","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843540?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:30","pubTimestamp":1788366658,"startTime":"0","endTime":"0","summary":"Kardigan, Inc. ($KARD) announced an update on their ongoing clinical study. The Phase 2b study, officially titled “A Phase 2b, Randomized, Double-B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kardigans-tonlamarsen-trial-targets-severe-hypertension-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kardigans-tonlamarsen-trial-targets-severe-hypertension-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4007","BK4211","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664435238","title":"Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2664435238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664435238?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:30","pubTimestamp":1788366649,"startTime":"0","endTime":"0","summary":"Kardigan, Inc. ($KARD) announced an update on their ongoing clinical study. Kardigan, Inc. (KARD) is running a long term Phase 3 study called “An O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kardigans-danicamtiv-heart-study-moves-forward-keeping-kard-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kardigans-danicamtiv-heart-study-moves-forward-keeping-kard-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","ISBC","KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173798","title":"Kardigan Price Target Cut to $46.00/Share from $51.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173798","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173798?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:06","pubTimestamp":1787663160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KARD/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662348167","title":"Kardigan price target lowered to $46 from $51 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662348167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662348167?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659237,"startTime":"0","endTime":"0","summary":"JPMorgan lowered the firm’s price target on Kardigan (KARD) to $46 from $51 and keeps an Overweight rating on the shares. The firm updated models i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-price-target-lowered-to-46-from-51-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-price-target-lowered-to-46-from-51-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KARD","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658099728","title":"Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658099728","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658099728?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:55","pubTimestamp":1786449342,"startTime":"0","endTime":"0","summary":"Kardigan (NASDAQ:KARD) reported quarterly losses of $(4.61) per share which missed the analyst consensus estimate of $(0.71) by 549.3 percent. This is a 0.65 percent increase over losses of $(4.64) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61104810/kardigan-q2-eps-4-61-misses-0-71-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599758","title":"Kardigan Q2 Per-Share Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599758","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599758?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:37","pubTimestamp":1786448261,"startTime":"0","endTime":"0","summary":"Kardigan (KARD) reported a Q2 GAAP loss Tuesday of $4.61 per diluted share, narrowing from a loss of $4.64 a year earlier.The company did not report revenue for the quarter.As of June 30, cash, cash equivalents and investments were $660.7 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992694","title":"Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992694","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992694?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:11","pubTimestamp":1786446708,"startTime":"0","endTime":"0","summary":"Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992479","title":"Kardigan reports Q2 EPS ($4.61) vs ($4.64) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992479?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:11","pubTimestamp":1786446688,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents and investments were $660.7M as of June 30, 2026, compared to $335.5M as of December 31, 2025. “Our IPO has positioned Kardi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-reports-q2-eps-4-61-vs-4-64-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-reports-q2-eps-4-61-vs-4-64-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999478","title":"Kardigan Q2 FY26 Net Loss Widens to $116.24 Million; R&D Expenses Rise to $56.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999478","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999478?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:01","pubTimestamp":1786446117,"startTime":"0","endTime":"0","summary":"Kardigan Q2 FY26 net loss widens to $116.24 million; R&D expenses rise to $56.37 millionKardigan posted a Q2 net loss of USD 116.24 million, widening from USD 57.45 million a year earlier.R&D expense ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLbbK3PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992879","title":"Kardigan - Q2 Net Loss was $116.20 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992879?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA8QDBPN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658799280","title":"Press Release: Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658799280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658799280?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":"directly targeting the underlying sarcomeric defects in genetic dilated. --  Danicamtiv is currently being evaluated in the Company's KINSHIP-DCM. --  Preclinical and clinical evidence linking danicamtiv treatment to. improvements in right ventricular function to be presented at the. upcoming European Society of Cardiology Congress . [Session:. Late-Breaking Basic and Translational Science; Sunday, Aug. 30th at 8:15. --  In July, the Company completed enrollment of Cohort 1 (myosin heavy. chain 7, or MYH7, and titin, or TTN, patients) of the Phase 2b. KINSHIP-DCM clinical trial and enrollment of the Phase 3 portion is now. underway. The Company expects to share Phase 2b topline data in the first. half of 2027.Ataciguat: soluble guanylate cyclase  activator in development for CAVS--  Ataciguat targets valvular interstitial cells to slow osteogenic and. calcific remodeling, an underlying driver of disease progression in. calcific aortic valve stenosis , and has demonstrated direct. myoca","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","BK4099","GDOC","AGT","BK4109","03160","LU2463526074.USD","IDNA","TM","MEDX","BK4007","ASH","BK4585","NVIB","KARD","BK4588","BK4604","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651635116","title":"TD Cowen Initiates Kardigan at Buy With $46 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651635116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651635116?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:28","pubTimestamp":1783942089,"startTime":"0","endTime":"0","summary":"TD Cowen Initiates Kardigan at Buy With $46 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COWN","TD","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115088","title":"Leerink Partners Initiates Kardigan at Outperform With $37 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115088","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115088?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:12","pubTimestamp":1783941126,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates Kardigan at Outperform With $37 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651152551","title":"Kardigan Initiated at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2651152551","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651152551?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:04","pubTimestamp":1783940640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KARD/analyst-ratings(END) Dow Jones NewswiresJuly 13, 2026 07:04 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190950","title":"Kardigan initiated with an Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190950?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:35","pubTimestamp":1783935310,"startTime":"0","endTime":"0","summary":"JPMorgan initiated coverage of Kardigan (KARD) with an Overweight rating and $51 price target The firm sees each of Kardigan’s mid-stage cardiovasc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","JPM","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190992","title":"Kardigan initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651190992?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:35","pubTimestamp":1783935305,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Kardigan (KARD) with a Buy rating and $40 price target The firm sees “value creating catalysts” for the company’s t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kardigan-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651193351","title":"Kardigan Inc : Jefferies Initiates Coverage with Buy Rating; Target Price $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2651193351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651193351?lang=en_us&edition=fundamental","pubTime":"2026-07-13 13:20","pubTimestamp":1783920030,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43C124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646828184","title":"Massive Insider Buying Spree Signals Bold Confidence in Kardigan’s Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2646828184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646828184?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:01","pubTimestamp":1782352876,"startTime":"0","endTime":"0","summary":"New insider activity at Kardigan, Inc. ( ($KARD) ) has taken place on June 24, 2026. Kardigan, Inc. has attracted significant insider interest as D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/massive-insider-buying-spree-signals-bold-confidence-in-kardigans-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/massive-insider-buying-spree-signals-bold-confidence-in-kardigans-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHAP.U","KARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646454358","title":"ARCH Venture Fund XIII Acquires $20 Million of Kardigan Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646454358","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646454358?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:19","pubTimestamp":1782332391,"startTime":"0","endTime":"0","summary":"ARCH Venture Fund XIII acquires $20 million of Kardigan common sharesARCH Venture Fund XIII bought 1,250,000 Kardigan common shares at $16, raising its stake to 15,042,035 shares.The filing lists ARCH","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL3vsfCm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ARCH Venture Fund XIII Acquires $20 Million of Kardigan Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KARD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}